EFFECTS OF PENICILLAMINE AND DIMERCAPROL ON TURNOVER OF COPPER IN PATIENTS WITH WILSON'S DISEASE
Authors:
- S.B. OsbornSOS.B. Osborn
- J.M. WalsheJWJ.M. Walshe
- 1 January 1958
- journal article
- Published by Elsevier in The Lancet
- Vol. 271 (7011) , 70-73
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- HEPATOLENTICULAR DEGENERATION (WILSON'S DISEASE)British Medical Bulletin, 1957
- Wilson's diseaseThe American Journal of Medicine, 1957
- Penicillamine, a new oral therapy for Wilson's diseaseThe American Journal of Medicine, 1956
- The place of bal in the therapy of Wilson's diseaseThe American Journal of Medicine, 1956
- STUDIES ON COPPER METABOLISM. XVI. RADIOACTIVE COPPER STUDIES IN NORMAL SUBJECTS AND IN PATIENTS WITH HEPATOLENTICULAR DEGENERATION 1Journal of Clinical Investigation, 1955
- Metabolism of copper in Wilson's disease and in normal subjectsThe American Journal of Medicine, 1954
- SCREENING TEST FOR EXCESSIVE URINARY COPPERThe Lancet, 1954
- The Effect of BAL (2,3-Dimercaptopropanol) on Hepatolenticular Degeneration (Wilson's Disease)New England Journal of Medicine, 1951